SCHEMBL2807682

SCHEMBL2807682

CCCCCC(=O)NS(=O)(=O)CC

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSP90AA1 P07900 1/20 0.54
FAAH O00519 6/20 0.52
MEN1 O00255 2/20 0.48
KMT2A Q03164 2/20 0.48
MAPK1 P28482 1/20 0.48
EPHX2 P34913 1/20 0.46
CES2 O00748 4/20 0.46
CES1 P23141 4/20 0.46
AKR1B1 P15121 1/20 0.44
CA1 P00915 1/20 0.44
CA2 P00918 1/20 0.44
PPARG P37231 4/20 0.43
PPARD Q03181 4/20 0.43
PPARA Q07869 4/20 0.43
TSHR P16473 3/20 0.43
GPR84 Q9NQS5 3/20 0.43
HDAC11 Q96DB2 3/20 0.43
ALDH1A1 P00352 2/20 0.43
TDP1 Q9NUW8 2/20 0.43
SLC22A6 Q4U2R8 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7468860 0.93 HSP90AA1 (0.45) HSP90AA1FAAHMEN1KMT2AMAPK1
SCHEMBL4732709 0.86 HSP90AA1 (0.53) HSP90AA1FAAHMEN1KMT2AMAPK1
SCHEMBL4732400 0.86 HSP90AA1 (0.53) HSP90AA1FAAHMEN1KMT2AMAPK1
SCHEMBL4731984 0.86 HSP90AA1 (0.53) HSP90AA1FAAHMEN1KMT2AMAPK1
SCHEMBL8292803 0.86 HSP90AA1 (0.53) HSP90AA1FAAHMEN1KMT2AMAPK1
SCHEMBL8292801 0.86 HSP90AA1 (0.53) HSP90AA1FAAHMEN1KMT2AMAPK1
SCHEMBL6309191 0.84 HDAC3 (0.50) MEN1KMT2ACES2CES1CA1
SCHEMBL91014 0.83 GPR84 (0.50) MEN1KMT2AEPHX2AKR1B1PPARG
SCHEMBL2810388 0.83 EPHX2 (0.62) HSP90AA1FAAHMEN1KMT2AMAPK1
SCHEMBL7180177 0.83 HSP90AA1 (0.54) HSP90AA1FAAHMEN1KMT2AMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9150556-B2 Benzimidazolone chymase inhibitors BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2015-10-06 US disclosed
US-20100240702-A1 Benzimidazolone Chymase Inhibitors BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2010-09-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100240702-A1 Benzimidazolone Chymase Inhibitors CMA1, SERPINB1, CPA3 HSP90AA1 1201/4885FAAH 1937/4885MEN1 1035/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.